Preview

Medical Genetics

Advanced search
Open Access Open Access  Restricted Access Subscription Access

The level of methylation of LINE-1 retrotransposon in chorionic villi in embryos from families with sporadic and recurrent miscarriage

https://doi.org/10.25557/2073-7998.2024.10.50-54

Abstract

Background. Epigenetic processes such as DNA methylation play an important role in maintaining a normal pregnancy and their disruption may be associated with spontaneous abortion. Earlier, we found an increased level of methylation of the retrotransposon LINE-1, which makes up about 17% of the human genome, in the chorionic villi of spontaneous abortions.

Aim: to analyze the level of methylation of the LINE-1 retrotransposon in chorionic villi in embryos from families with sporadic and recurrent miscarriage.

Methods. The present study analyzes the differences in the level of methylation in chorionic villi of 46 induced abortions and spontaneous abortions from 155 families with sporadic miscarriage and 127 families with recurrent miscarriage. The methylation level of LINE-1 was assessed using targeted bisulfite massive parallel sequencing.

Results. No significant differences in LINE-1 methylation levels were found between the groups with recurrent and sporadic miscarriage (p>0.05). However, the LINE-1 methylation level was significantly higher compared to induced abortions (40.2 ± 2.2%) in spontaneous abortions with monosomy X from families with recurrent (42.0 ± 4.5%, p=0.04) and sporadic miscarriage (43.1 ± 5.2%, p=0.03), and in spontaneous abortions with trisomy 16 from families with sporadic miscarriage (43.1 ± 3.9%, p<0.001).

Conclusion. Abnormal methylation level of LINE-1 may be a marker of the death of part of the embryos in both sporadic and recurrent miscarriage.

About the Authors

V. V. Demeneva
Tomsk National Research Medical Center of the Russian Academy of Sciences, Research Institute of Medical Genetics
Russian Federation

10, Naberejnaya Ushaiki, Tomsk, 634050



E. N. Tolmacheva
Tomsk National Research Medical Center of the Russian Academy of Sciences, Research Institute of Medical Genetics
Russian Federation

10, Naberejnaya Ushaiki, Tomsk, 634050



S. A. Filatova
Tomsk National Research Medical Center of the Russian Academy of Sciences, Research Institute of Medical Genetics; Tomsk State University
Russian Federation

10, Naberejnaya Ushaiki, Tomsk, 634050

36, Lenin Avenue, Tomsk, 634050



A. S. Zuev
Tomsk National Research Medical Center of the Russian Academy of Sciences, Research Institute of Medical Genetics
Russian Federation

10, Naberejnaya Ushaiki, Tomsk, 634050



A. S. Ushakova
Tomsk National Research Medical Center of the Russian Academy of Sciences, Research Institute of Medical Genetics; Tomsk State University
Russian Federation

10, Naberejnaya Ushaiki, Tomsk, 634050

36, Lenin Avenue, Tomsk, 634050



O. Yu. Vasilyeva
Tomsk National Research Medical Center of the Russian Academy of Sciences, Research Institute of Medical Genetics
Russian Federation

10, Naberejnaya Ushaiki, Tomsk, 634050



E. A. Sazhenova
Tomsk National Research Medical Center of the Russian Academy of Sciences, Research Institute of Medical Genetics
Russian Federation

10, Naberejnaya Ushaiki, Tomsk, 634050



T. V. Nikitina
Tomsk National Research Medical Center of the Russian Academy of Sciences, Research Institute of Medical Genetics
Russian Federation

10, Naberejnaya Ushaiki, Tomsk, 634050



S. A. Vasiliev
Tomsk National Research Medical Center of the Russian Academy of Sciences, Research Institute of Medical Genetics; Tomsk State University
Russian Federation

10, Naberejnaya Ushaiki, Tomsk, 634050

36, Lenin Avenue, Tomsk, 634050



References

1. Quenby S., Gallos I.D., Dhillon-Smith R.K. et al. Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss. The Lancet. 2021; 10285: 1658-1667. doi:10.1016/S0140-6736(21)00682-6.

2. Coomarasamy A., Dhillon-Smith R.K., Papadopoulou A. et al. Recurrent miscarriage: evidence to accelerate action. The Lancet. 2021; 10285: 1675-1682. doi:10.1016/S0140-6736(21)00681-4

3. Devall A. J., Coomarasamy A. Sporadic pregnancy loss and recurrent miscarriage Best Practice & Research Clinical Obstetrics & Gynaecology. 2020; 69: 30-39. doi:10.1016/j.bpobgyn.2020.09.002

4. Feldberg D. Epigenetic aspects of human reproduction and early pregnancy. Sex, Gender, and Epigenetics. Academic Press. 2023; 237-243. doi:10.1016/B978-0-12-823937-7.00018-3

5. Tisato V., Silva J.A., Scarpellini F. et al. Epigenetic role of LINE-1 methylation and key genes in pregnancy maintenance. Scientific Reports. 2024; 1: 3275. doi:10.1038/s41598-024-53737-2

6. Lou C., Goodier J. L., Qiang R. A potential new mechanism for pregnancy loss: considering the role of LINE-1 retrotransposons in early spontaneous miscarriage. Reproductive Biology and Endocrinology. 2020; 18: 6. doi:10.1186/s12958-020-0564-x

7. Vasilyev S.A., Tolmacheva E.N., Vasilyeva O.Y. et al. LINE-1 retrotransposon methylation in chorionic villi of first trimester miscarriages with aneuploidy. J Assist Reprod Genet. 2021; 38(1): 139–149. doi:10815-020-02003-1.

8. Lebedev I.N., Ostroverkhova N.V., Nikitina T.V. et al. Features of chromosomal abnormalities in spontaneous abortion cell culture failures detected by interphase FISH analysis. Eur. J. Hum. Genet. 2004; 12:513–520. doi: 10.1038/sj.ejhg.5201178

9. Vasilyev S.A., Timoshevsky V.A., Lebedev I.N. Cytogenetic mechanisms of aneuploidy in somatic cells of chemonuclear industry professionals with incorporated plutonium-239. Russ. J. Genet. 2010; 46:1381–1385. doi: 10.1134/S1022795410110141

10. Vasilyev S.A., Markov A.V., Vasilyeva O.Yu. et al. Method of targeted bisulfite massive parallel sequencing of the human LINE-1 retrotransposon promoter. MethodsX. 2021;8, 101445. doi: 10.1016/j.mex.2021.101445

11. Lim J.H., Kang Y.J., Lee B.Y. et al. Epigenome-wide base-resolution profiling of DNA methylation in chorionic villi of fetuses with Down syndrome by methyl-capture sequencing. Clin Epigenet. 2019; 11(180). doi:10.1186/s13148-019-0756-4

12. Lim J.H., Kim S.Y., Han J.Y et al. Comprehensive investigation of DNA methylation and gene expression in trisomy 21 placenta. Placenta. 2016; 42:17-24. doi: 10.1016/j.placenta.2016.03.012.

13. Tolmacheva E.N., Vasilyev S.A., Nikitina T.V. et al. Identification of differentially methylated genes in first-trimester placentas with trisomy 16. Sci Rep. 2022; 12(1):1166. doi: 10.1038/s41598-021-04107-9.

14. Lou C., Qiang R., Wu H. et al. Expression of LINE-1 retrotransposon in early human spontaneous abortion tissues. Medicine (Baltimore). 2022; 101(49):e31964. doi: 10.1097/MD.0000000000031964.

15. Tisato V., Silva J.A., Scarpellini F. et al. Epigenetic role of LINE-1 methylation and key genes in pregnancy maintenance. Sci Rep. 2024; 14(1):3275. doi: 10.1038/s41598-024-53737-2.

16. Malki S., van der Heijden G.W., O’Donnell K.A., et al. A role for retrotransposon LINE-1 in fetal oocyte attrition in mice. Dev Cell. 2014; 29(5):521-533. doi: 10.1016/j.devcel.2014.04.027.

17. Yuan P., Guo Q., Guo H. et al. The methylome of a human polar body reflects that of its sibling oocyte and its aberrance may indicate poor embryo development. Hum Reprod. 2021; 36(2):318-330. doi: 10.1093/humrep/deaa292


Review

For citations:


Demeneva V.V., Tolmacheva E.N., Filatova S.A., Zuev A.S., Ushakova A.S., Vasilyeva O.Yu., Sazhenova E.A., Nikitina T.V., Vasiliev S.A. The level of methylation of LINE-1 retrotransposon in chorionic villi in embryos from families with sporadic and recurrent miscarriage. Medical Genetics. 2024;23(10):50-54. (In Russ.) https://doi.org/10.25557/2073-7998.2024.10.50-54

Views: 98


ISSN 2073-7998 (Print)